A. Veillard

J. Pignon, R. Stephens, L. Seymour, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.

R. Kimmig, L. Elit, G. Scambia, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial

V. Gebski, M. Dimopoulos, I. Vergote, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.

J. Kench, S. Fox, L. Horvath, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease.

W. Selby, S. Travis, I. Lawrance, 2013, Journal of Crohn's & colitis.

Primary congenital glaucoma outcomes: lessons from 23 years of follow-up.

S. Hing, F. Billson, J. Grigg, 2015, American journal of ophthalmology.

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.

J. Pignon, L. Seymour, F. Shepherd, 2013, Lung cancer.

Neuropathological and Neuroradiological Spectrum of Pediatric Malignant Gliomas: Correlation With Outcome

P. Varlet, N. Boddaert, S. Puget, 2011, Neurosurgery.

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.

J. Pignon, D. Planchard, J. Soria, 2012, Lung cancer.

Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.

Xiaoying Zhang, B. Rose, A. Hong, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

M. Stockler, P. Beale, D. Sommeijer, 2018, Cancer Chemotherapy and Pharmacology.

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).

J. Forbes, V. Gebski, P. Francis, 2014, Breast.

Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?

M. Stockler, M. Millward, B. Hughes, 2015, European journal of cancer.

Rising prevalence of human papillomavirus–related oropharyngeal cancer in Australia over the last 2 decades

Jonathan R. Clark, Xiaoying Zhang, B. Rose, 2016, Head & neck.

Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone

V. Gebski, R. Simes, A. Coates, 2013, SpringerPlus.

Does chemotherapy shorten the latency interval of radiation-induced sarcomas?

M. Tattersall, A. Hong, A. Veillard, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.

Xiaoying Zhang, B. Rose, A. Hong, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Final analysis of a randomized comparison of letrozole (Let) vs observation (Obs) as late reintroduction of adjuvant endocrine therapy (AET) for postmenopausal women with hormone receptor positive (HR+) breast cancer (BC) after completion of prior AET: ANZBCTG 0501 (LATER).

J. Forbes, V. Gebski, F. Boyle, 2015 .

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials.

J. Pignon, L. Seymour, F. Shepherd, 2012 .